Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery
Online ISSN : 2758-8777
Print ISSN : 2186-9545
Clinical feature after disease progression in thyroid carcinoma patients treated with lenvatinib
Chie Masaki, Kiminori Sugino, Takayuki Ishigaki, Tomoaki Tanaka, Yuna Ogimi, Tadatoshi Osaku, Junko Akaishi, Tomonori Yabuta, Kiyomi y. Hames., Chisato Tomoda, Akifumi Suzuki, Kenichi Matsuzu, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Koichi Ito
Author information
Keywords: thyroid carcinoma, lenvatinib, RECIST PD, Clinical PD, performance status
JOURNAL FREE ACCESS FULL-TEXT HTML

2018 Volume 35 Issue 2 Pages 129-133

Details
Full-text HTML Download PDF (1876K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract
[in Japanese]
Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc/4.0/deed.ja
Previous article Next article
Favorites & Alerts

Recently viewed articles
Successor

Official Journal of the Japan Association of Endocrine Surgery

Share this page
feedback
 Top